Polyphenols and Glucose Homeostasis in Humans

Journal of the Academy of Nutrition and Dietetics

Volumn 112, Issue 6, 2012, Pages 808-815

  de Bock, Martin ^a   Derraik, José G B ^a   Cutfield, Wayne S ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Diet; Glucose homeostasis; Nutraceuticals; Polyphenols

Indexed keywords

POLYPHENOL;

ARTICLE; DIET; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; HOMEOSTASIS; HUMANS; POLYPHENOLS;

EID: 84861393904     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2012.01.018     Document Type: Article

References (91)

1. The United States of Diabetes: Challenges and Opportunities in the Decade Ahead 2010, UnitedHealth Center for Health Reform & Modernization, United Health Group, Minnetonka, MN, Working Paper No. 5.
2. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: Food sources and bioavailability. Am J Clin Nutr 2004, 79(5):727-747.
3. Torabian S., Haddad E., Rajaram S., Banta J., Sabaté J. Acute effect of nut consumption on plasma total polyphenols, antioxidant capacity and lipid peroxidation. J Hum Nutr Diet 2009, 22(1):64-71.
4. Mukhtar H., Ahmad N. Tea polyphenols: Prevention of cancer and optimizing health. Am J Clin Nutr 2000, 71(6 suppl):1698S-1702S.
5. Scalbert A., Johnson I.T., Saltmarsh M. Polyphenols: Antioxidants and beyond. Am J Clin Nutr 2005, 81(1 suppl):215S-217S.
6. Scalbert A., Manach C., Morand C., Remesy C., Jimenez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005, 45(4):287-306.
7. Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: Chemistry, bioavailability and effects on health. Nat Prod Rep 2009, 26(8):1001-1043.
8. Clifford M. Diet-derived phenols in plasma and tissues and their implications for health. Planta Med 2004, 70(12):1103-1114.
9. Knekt P., Kumpulainen J., Jarvinen R., et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002, 76(3):560-568.
10. Bravo L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998, 56(11):317-333.
11. Pérez-Jiménez J., Neveu V., Vos F., Scalbert A. Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: An application of the phenol-explorer database. J Agric Food Chem 2010, 58(8):4959-4969.
12. Phenol-Explorer v1.5.7. Phenol Explorer website, Accessed June 6, 2011. http://www.phenol-explorer.eu/.
13. Kuhnau J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 1976, 24:117-191.
14. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000, 130(8 suppl):2073S-2085S.
15. Pérez-Jiménez J., Fezeu L., Touvier M., et al. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr 2011, 93(6):1220-1228.
16. Ahmad M.F., Ashraf S.A., Ahmad F.A., Ansari J., Siddiquee M.R.A. Nutraceutical market and its regulation. Am J Food Technol 2011, 6(5):342-347.
17. Hanhineva K., Törrönen R., Bondia-Pons I., et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010, 11(4):1365-1402.
18. Salazar-Martinez E., Willett W.C., Ascherio A., et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 2004, 140(1):1-8.
19. van Dam R.M., Willett W.C., Manson J.E., Hu F.B. Coffee, caffeine, and risk of type 2 diabetes. Diabetes Care 2006, 29(2):398-403.
20. Hu G., Jousilahti P., Peltonen M., Bidel S., Tuomilehto J. Joint association of coffee consumption and other factors to the risk of type 2 diabetes: A prospective study in Finland. Int J Obes 2006, 30(12):1742-1749.
21. Hamer M., Witte D.R., Mosdøl A., Marmot M.G., Brunner E.J. Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: The Whitehall II study. Br J Nutr 2008, 100(5):1046-1053.
22. Song Y., Manson J., Buring J., Sesso H., Liu S. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: A prospective study and cross-sectional analysis. J Am Coll Nutr 2005, 24(5):376-384.
23. Pereira M., Parker E., Folsom A. Coffee consumption and risk of type 2 diabetes mellitus: An 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 2006, 166(12):1311-1316.
24. Greenberg J.A., Axen K.V., Schnoll R., Boozer C.N. Coffee, tea and diabetes: The role of weight loss and caffeine. Int J Obes Relat Metab Disord 2005, 29(9):1121-1129.
25. Odegaard A.O., Pereira M.A., Koh W.-P., et al. Coffee, tea, and incident type 2 diabetes: The Singapore Chinese Health Study. Am J Clin Nutr 2008, 88(4):979-985.
26. Iso H., Date C., Wakai K., et al. The Relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006, 144(8):554-562.
27. Jing Y., Han G., Hu Y., et al. Tea consumption and risk of type 2 diabetes: A meta-analysis of cohort studies. J Gen Intern Med 2009, 24(5):557-562.
28. Josic J., Olsson A., Wickeberg J., Lindstedt S., Hlebowicz J. Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: A randomized controlled trial. Nutr J 2010, 9:63.
29. Nagao T., Meguro S., Hase T., et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity 2008, 17(2):310-317.
30. Brown A., Lane J., Coverly J., et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: Randomized controlled trial. Br J Nutr 2009, 101(06):886-894.
31. Venables M., Hulston C., Cox H., Jeukendrup A. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr 2008, 87(3):778-784.
32. Fukino Y., Ikeda A., Maruyama K., et al. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 2007, 62(8):953-960.
33. MacKenzie T., Leary L., Brooks W. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: Double-blind randomized study. Metabolism 2007, 56(10):1340-1344.
34. Bryans J., Judd P., Ellis P. The effect of consuming instant black tea on postprandial plasma glucose and insulin concentrations in healthy humans. J Am Coll Nutr 2007, 26(5):471-477.
35. Ryu O., Lee J., Lee K., et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 2006, 71(3):356-358.
36. Fukino Y., Shimbo M., Aoki N., Okubo T., Iso H. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol 2005, 51(5):335-342.
37. Tsuneki H., Ishizuka M., Terasawa M., et al. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 2004, 4(1):18.
38. Hosoda K., Wang M., Liao M., et al. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 2003, 26(6):1714-1718.
39. Fuhr U., Kummert A.L. The fate of naringin in humans: A key to grapefruit juice-drug interactions?. Clin Pharmacol Ther 1995, 58(4):365-373.
40. Janszky I., Mukamal K., Ljung R., et al. Chocolate consumption and mortality following a first acute myocardial infarction: The Stockholm Heart Epidemiology Program. J Intern Med 2009, 266(3):248-257.
41. Almoosawi S., Fyfe L., Ho C., Al-Dujaili E. The effect of polyphenol-rich dark chocolate on fasting capillary whole blood glucose, total cholesterol, blood pressure and glucocorticoids in healthy overweight and obese subjects. Br J Nutr 2010, 103(06):842-850.
42. Grassi D., Desideri G., Necozione S., et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 2008, 138(9):1671-1676.
43. Grassi D., Lippi C., Necozione S., Desideri G., Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 2005, 81(3):611-614.
44. Grassi D., Necozione S., Lippi C., et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 2005, 46(2):398-405.
45. Davison K., Coates A., Buckley J., Howe P. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes 2008, 32(8):1289-1296.
46. Muniyappa R., Hall G., Kolodziej T., et al. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr 2008, 88(6):1685-1696.
47. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339(8808):1523-1526.
48. Kar P., Laight D., Rooprai H., Shaw K., Cummings M. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: A double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabet Med 2009, 26(5):526-531.
49. Hollis J., Houchins J., Blumberg J., Mattes R. Effects of concord grape juice on appetite, diet, body weight, lipid profile, and antioxidant status of adults. J Am Coll Nutr 2009, 28(5):574-582.
50. Banini A., Boyd L., Allen J., Allen H., Sauls D. Muscadine grape products intake, diet and blood constituents of non-diabetic and type 2 diabetic subjects. Nutrition 2006, 22(11-12):1137-1145.
51. Naissides M., Mamo J., James A., Pal S. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Atherosclerosis 2006, 185(2):438-445.
52. Gin H., Rigalleau V., Caubet O., Masquelier J., Aubertin J. Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro. Metabolism 1999, 48(9):1179-1183.
53. Saiko P., Szakmary A., Jaeger W., Szekeres T. Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat Res 2008, 658(1-2):68-94.
54. Brasnyó P., Molnár G.A., Mohás M., et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 2011, 106:383-389.
55. Choquette S., Riesco E.́, Cormier É́, et al. Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: A 6-month double-blind controlled trial. Br J Nutr 2011, 105(8):1199-1209.
56. Liu Z., Chen Y., Ho S., Ho Y., Woo J. Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: A 6-mo double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes. Am J Clin Nutr 2010, 91(5):1394-1401.
57. Ho S., Chen Y., Ho S., Woo J. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: A double-blind, randomized, placebo-controlled trial. Menopause 2007, 14(5):905-912.
58. Jayagopal V., Albertazzi P., Kilpatrick E., et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002, 25(10):1709-1714.
59. Duncan A., Underhill K., Xu X., et al. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 1999, 84(10):3479-3484.
60. Nagata C. Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int J Epidemiol 2000, 29(5):832-836.
61. Cassidy A., Albertazzi P., Nielsen I., et al. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 2006, 65(01):76-92.
62. Serra Majem L., Roman B., Estruch R. Scientific evidence of interventions using the Mediterranean diet: A systematic review. Nutr Rev 2006, 64:S27-S47.
63. Covas M., Nyyssönen K., Poulsen H., et al. The effect of polyphenols in olive oil on heart disease risk factors. Ann Intern Med 2006, 145(5):394-395.
64. Murtaugh M., Jacobs D., Jacob B., Steffen L., Marquart L. Epidemiological support for the protection of whole grains against diabetes. Proc Nutr Soc 2003, 62(1):143-149.
65. De Munter J., Hu F., Spiegelman D., Franz M., van Dam R. Whole grain, bran, and germ intake and risk of type 2 diabetes: A prospective cohort study and systematic review. PLoS Med 2007, 4(8):e261.
66. Day A.J. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett 2000, 468(2-3):166-170.
67. Rosensweig N.S. Adult human milk intolerance and intestinal lactase deficiency. A review. J Dairy Sci 1969, 52(5):585-587.
68. Plumb G.W., Garcia-Conesa M.T., Kroon P.A., et al. Metabolism of chlorogenic acid by human plasma, liver, intestine and gut microflora. J Sci Food Agric 1999, 79(3):390-392.
69. Drasar B.S., Barrow P. Intestinal microbiology 1985, American Society for Microbiology, Washington, DC.
70. Lachman H.M., Papolos D.F., Saito T., et al. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenet Genomics 1996, 6(3):243-250.
71. Nielsen S.E., Breinholt V., Justesen U., Cornett C., Dragsted L.O. In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 1998, 28(4):389-401.
72. Strassburg C.P., Manns M.P., Tukey R.H. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem 1998, 273(15):8719-8726.
73. Fevery J., Blanckaert N., Heirwegh K.P.M., Préaux A.M., Berthelot P. Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease. J Clin Invest 1977, 60(5):970-979.
74. Walle T., Eaton E.A., Walle U.K. Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochem Pharmacol 1995, 50(5):731-734.
75. Burchell B., Brierley C.H., Rance D. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci 1995, 57(20):1819-1831.
76. Burchell B., Coughtrie M.W. Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation. Environ Health Perspect 1997, 105(suppl 4):739-747.
77. Koga T., Meydani M. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am J Clin Nutr 2001, 73(5):941-948.
78. Goldberg D., Yan J., Soleas G. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003, 36(1):79-87.
79. Lotito S., Frei B. Relevance of apple polyphenols as antioxidants in human plasma: Contrasting in vitro and in vivo effects. Free Radic Biol Med 2004, 36(2):201-211.
80. Hackett A.M., Griffiths L.A., Broillet A., Wermeille M. The metabolism and excretion of (+)-[14 C] cyanidanol-3 in man following oral administration. Xenobiotica 1983, 13(5):279-286.
81. Bell J.R.C., Donovan J.L., Wong R., et al. (+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine. Am J Clin Nutr 2000, 71(1):103-108.
82. Naismith D., Akinyanju P., Szanto S., Yudkin J. The effect in volunteers of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Ann Nutr Metab 1970, 12(3):144-151.
83. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27(5):1047-1053.
84. Goldberg D.M., Yan J., Ng E., et al. A global survey of trans-resveratrol concentrations in commercial wines. Am J Enol Viticul 1995, 46(2):159-165.
85. Resveratrol. Biotivia Bioceuticals LLC website Accessed November 8, 2011. http://www.biotivia.com/resveratrol.html.
86. Herath D., Henson S., Cranfield J. A note on the economic rationale for regulating health claims on functional foods and nutraceuticals: the case of Canada. Health Law Rev 2006, 15(1):23-32.
87. Hayakawa F., Kimura T., Hoshino N., Ando T. DNA cleavage activities of (-)-epigallocatechin, (-)-epicatechin, (+)-catechin, and (-)-epigallocatechin gallate with various kind of metal ions. Biosci Biotechnol Biochem 1999, 63(9):1654-1656.
88. Yamanaka N., Oda O., Nagao S. Green tea catechins such as (-)-epicatechin and (-)-epigallocatechin accelerate Cu2+-induced low density lipoprotein oxidation in propagation phase. FEBS Lett 1997, 401(2-3):230-234.
89. Singh V., Ahmad S., Rao G. Prooxidant and antioxidant properties of iron-hydroquinone and iron-1, 2, 4-benzenetriol complex. Implications for benzene toxicity. Toxicology 1994, 89(1):25-33.
90. Hayakawa F., Kimura T., Maeda T., et al. DNA cleavage reaction and linoleic acid peroxidation induced by tea catechins in the presence of cupric ion. Biochim Biophys Acta 1997, 1336(2):123-131.
91. Sahu S., Gray G. Interactions of flavonoids, trace metals, and oxygen: Nuclear DNA damage and lipid peroxidation induced by myricetin. Cancer Lett 1993, 70(1-2):73-79.